Advertisement

#GVHD (graft-versus-host disease)

Bone marrow stem cells

What’s New in Combatting Chronic Graft-Versus-Host-Disease

Rare Blood Cancer Patient Is Cancer-Free After Clinical Trial

T Cell Cancer Discovery Turns 40

Bone marrow stem cells

What’s New in Combatting Chronic Graft-Versus-Host-Disease

Rare Blood Cancer Patient Is Cancer-Free After Clinical Trial

T Cell Cancer Discovery Turns 40

Myeloma cells (purple) in a patient's bone marrow, with a few normal cells in pink in the background.

New Approach Could Make Bone Marrow Transplants Safer, Stronger

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Dispatches From the Microbial Frontier of Cancer Research

Hutch scientists explore how our immune system can team with our microbiome to fight cancer and other life-threatening diseases.

A T cell (blue) attacking an infected cell (green). There are several types of T cells, including naive T cells, which have never encountered an antigen.

Can Chronic Graft-Versus-Host Disease Be Prevented?

Removing naive T cells before a stem cell transplant in certain cancer patients may prevent chronic graft-versus-host disease.

The Dangers Of Septic Shock In Blood Cancer Patients

More than two-thirds of patients with blood cancer who experienced septic shock died within 28 days, finds MD Anderson Cancer Center.

Stem Cell Transplant (Bone Marrow Transplant)

Motoko Koyama, MD, PhD

Mystery Solved: How Graft-Versus-Host Disease Starts in the Gut

Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it

Deanna Saltzman (left) tests her lung function as Guang-Shing Cheng, MD (center), and Lisa Chung look on.

Earlier Detection for a Deadly Lung Disease

‘To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.’

Studies Offer Glimpses into the Future of Medicine for Blood Cancers

ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.

Scientists discuss research at the Microbiome Research Initiative 2018 Symposium at Fred Hutch. From left: David Fredricks, MD; Yasmine Belkaid, PhD; Robert Jenq, MD; David Cook, PhD; Stephen O’Keefe, MD; Johanna Lampe, PhD, RD; Neelendu Dey, MD.

Fred Hutch Deepens Its Focus on the Microbiome

The Microbiome Research Initiative symposium highlighted research on how the gut interacts with the immune system and its effects on cancer.

FDA Awards 12 Grants to Fund Clinical Trials for Treatment of Rare Diseases

Trials for head and neck cancer, pancreatic cancer, acute myeloid leukemia and myelodysplastic syndrome, among others, will receive funding.

Brother’s Stem Cells Make Remission Possible for Pediatric Leukemia Patient

“When your doctor says the No. 1 pediatric stem cell transplant hospital in the world is 90 minutes from your house, you don’t question it...

Advertisement

Features

Newsfeed